| Entry |
|
| Name |
Glycosaminoglycan degradation - Homo sapiens (human) |
| Class |
Metabolism; Glycan biosynthesis and metabolism
|
| Pathway map |

|
| Module |
|
| Network |
nt06012 Glycosaminoglycan degradation |
| Element |
| N00610 | Dermatan sulfate degradation |
| N00615 | Heparan sulfate degradation |
| N00623 | Keratan sulfate degradation |
|
| Drug |
| D11812 | Pabinafusp alfa (genetical recombination) (JAN) |
| D12806 | Tividenofusp alfa (USAN/INN) |
|
| Other DBs |
|
| Organism |
Homo sapiens (human) [GN: hsa]
|
| Gene |
| 60495 | HPSE2; heparanase 2 (inactive) [KO:K07965] [EC:3.2.1.-] |
|
| Compound |
|
| Reference |
|
| Authors |
Greiling H, Stuhlsatz HW, Cantz M, Gehler J |
| Title |
Increased urinary excretion of keratan sulfate in fucosidosis. |
| Journal |
|
| Reference |
|
| Authors |
Fuchs W, Beck M, Kresse H |
| Title |
Intralysosomal formation and metabolic fate of N-acetylglucosamine 6-sulfate from keratan sulfate. |
| Journal |
|
Related pathway |
| hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate |
| hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate |
| hsa00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin |
|
| KO pathway |
|